169 related articles for article (PubMed ID: 37821199)
1. Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders.
Failing C; Blase JR; Walkovich K
Rheum Dis Clin North Am; 2023 Nov; 49(4):841-860. PubMed ID: 37821199
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation.
Paskiewicz A; Niu J; Chang C
Autoimmun Rev; 2023 Nov; 22(11):103442. PubMed ID: 37683818
[TBL] [Abstract][Full Text] [Related]
3. Next Generation Sequencing for Detecting Somatic
López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
Front Immunol; 2021; 12():656356. PubMed ID: 33995372
[TBL] [Abstract][Full Text] [Related]
4. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.
Hafezi N; Zaki-Dizaji M; Nirouei M; Asadi G; Sharifinejad N; Jamee M; Erfan Rasouli S; Hamedifar H; Sabzevari A; Chavoshzadeh Z; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
Pediatr Allergy Immunol; 2021 Oct; 32(7):1519-1532. PubMed ID: 33963613
[TBL] [Abstract][Full Text] [Related]
5. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
Consonni F; Gambineri E; Favre C
Ann Hematol; 2022 Mar; 101(3):469-484. PubMed ID: 35059842
[TBL] [Abstract][Full Text] [Related]
6. Presentation and diagnosis of autoimmune lymphoproliferative syndrome (ALPS).
Lambert MP
Expert Rev Clin Immunol; 2021 Nov; 17(11):1163-1173. PubMed ID: 34503378
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders.
Magerus A; Rensing-Ehl A; Rao VK; Teachey DT; Rieux-Laucat F; Ehl S
J Allergy Clin Immunol; 2024 Jan; 153(1):67-76. PubMed ID: 37977527
[TBL] [Abstract][Full Text] [Related]
8. Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS).
Casamayor-Polo L; López-Nevado M; Paz-Artal E; Anel A; Rieux-Laucat F; Allende LM
Crit Rev Clin Lab Sci; 2021 Jun; 58(4):253-274. PubMed ID: 33356695
[TBL] [Abstract][Full Text] [Related]
9. FAS-mediated apoptosis impairment in patients with ALPS/ALPS-like phenotype carrying variants on CASP10 gene.
Miano M; Cappelli E; Pezzulla A; Venè R; Grossi A; Terranova P; Palmisani E; Maggiore R; Guardo D; Lanza T; Calvillo M; Micalizzi C; Pierri F; Vernarecci C; Beccaria A; Corsolini F; Lanciotti M; Russo G; Ceccherini I; Dufour C; Fioredda F
Br J Haematol; 2019 Nov; 187(4):502-508. PubMed ID: 31309545
[TBL] [Abstract][Full Text] [Related]
10. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.
López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM
Front Immunol; 2021; 12():671755. PubMed ID: 34447369
[TBL] [Abstract][Full Text] [Related]
11. Advances in autoimmune lymphoproliferative syndromes.
Madkaikar M; Mhatre S; Gupta M; Ghosh K
Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
[TBL] [Abstract][Full Text] [Related]
12. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).
Teachey DT; Seif AE; Grupp SA
Br J Haematol; 2010 Jan; 148(2):205-16. PubMed ID: 19930184
[TBL] [Abstract][Full Text] [Related]
13. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.
Rieux-Laucat F; Magérus-Chatinet A; Neven B
J Clin Immunol; 2018 Jul; 38(5):558-568. PubMed ID: 29911256
[TBL] [Abstract][Full Text] [Related]
14. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Sneller MC; Wang J; Dale JK; Strober W; Middelton LA; Choi Y; Fleisher TA; Lim MS; Jaffe ES; Puck JM; Lenardo MJ; Straus SE
Blood; 1997 Feb; 89(4):1341-8. PubMed ID: 9028957
[TBL] [Abstract][Full Text] [Related]
15. Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS).
Yokoyama S; Perera PY; Terawaki S; Watanabe N; Kaminuma O; Waldmann TA; Hiroi T; Perera LP
J Clin Immunol; 2015 Oct; 35(7):661-7. PubMed ID: 26453583
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune lymphoproliferative syndrome: an update and review of the literature.
Shah S; Wu E; Rao VK; Tarrant TK
Curr Allergy Asthma Rep; 2014 Sep; 14(9):462. PubMed ID: 25086580
[TBL] [Abstract][Full Text] [Related]
17. The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders.
Oliveira Mendonça L; Matucci-Cerinic C; Terranova P; Casabona F; Bovis F; Caorsi R; Fioredda F; Palmisani E; Grossi A; Guardo D; Bustaffa M; Volpi S; Ceccherini I; Ravelli A; Dufour C; Miano M; Gattorno M
Rheumatology (Oxford); 2022 Feb; 61(2):696-704. PubMed ID: 33909886
[TBL] [Abstract][Full Text] [Related]
18. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).
Li P; Huang P; Yang Y; Hao M; Peng H; Li F
Clin Rev Allergy Immunol; 2016 Feb; 50(1):55-63. PubMed ID: 25663566
[TBL] [Abstract][Full Text] [Related]
19. What's up in the ALPS.
Rieux-Laucat F
Curr Opin Immunol; 2017 Dec; 49():79-86. PubMed ID: 29073495
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]